about
Adenosine-associated delivery systemsLacosamide: a new approach to target voltage-gated sodium currents in epileptic disordersAdenosine hypothesis of schizophrenia--opportunities for pharmacotherapyComonitoring of adenosine and dopamine using the Wireless Instantaneous Neurotransmitter Concentration System: proof of principleAstrocytes derived from fetal neural progenitor cells as a novel source for therapeutic adenosine delivery.Adenosine kinase as a target for therapeutic antisense strategies in epilepsy.Therapeutic epilepsy research: from pharmacological rationale to focal adenosine augmentation.Working memory and the homeostatic control of brain adenosine by adenosine kinaseGlycine transporter 1 is a target for the treatment of epilepsy.The adenosine kinase hypothesis of epileptogenesisSilk polymer-based adenosine release: therapeutic potential for epilepsy.Adenosine dysfunction in astrogliosis: cause for seizure generation?Adenosine as a neuromodulator in neurological diseases.Adenosine augmentation therapies (AATs) for epilepsy: prospect of cell and gene therapies.Antiepileptic effects of silk-polymer based adenosine release in kindled rats.GABAB Receptor Blockade Prevents Antiepileptic Action of Ghrelin in the Rat Hippocampus.Embryonic stem cell-derived neural precursor grafts for treatment of temporal lobe epilepsy.Engineered adenosine-releasing cells for epilepsy therapy: human mesenchymal stem cells and human embryonic stem cellsMechanisms of drug resistance in epilepsy: relevance for antiepileptic drug discovery.The Epilepsy Spectrum: Targeting Future Research Challenges.Human mesenchymal stem cell grafts engineered to release adenosine reduce chronic seizures in a mouse model of CA3-selective epileptogenesis.Ozone protective effects against PTZ-induced generalized seizures are mediated by reestablishment of cellular redox balance and A1 adenosine receptors.
P2860
Q26785351-D4EE4519-988F-4256-BD08-7717A1D2074BQ28833549-7C5DE4FD-8730-4C19-BA3C-80BDF14AAD6FQ30457808-AAD431CB-47BD-43D7-8891-C33A0B482312Q33782226-E611E133-84CB-441F-BEFD-4ACC4EAAEE47Q34193177-B59AC0B6-69D1-4C96-8844-73AB5EBBB11FQ34788009-AE9BA6BA-F3B7-4589-930E-D138ED2FACAEQ34997511-7BA15537-6CA1-4330-9AB9-AD4786C37BFFQ36007799-B87BDE61-C898-47FF-A463-05D9CD7C022BQ36304849-710CCB05-9AA1-43B7-BEC4-CFEF5CEE2DE2Q36515651-4D143C52-4915-4349-B79E-75CA17443704Q36819103-EEBBE1DA-1325-4AAA-A6BE-DFFDCD9022AEQ36923994-62BDCB55-C08B-4A2B-838D-44A5F6D6C7A0Q36974004-7D193772-DB9B-41E5-AECF-E9D7C6004696Q37269991-6EDF06DB-9215-4196-98F3-B83EB078BDB4Q37310106-023681B4-96A9-401E-BB18-CBA57584EBA1Q37358779-1B0B101D-544A-4F2B-98E1-AE2873D4B04DQ37426962-A2E9E1F2-82E4-4FF2-AA78-FE972332F2C9Q37426965-6A1ADFAE-EAEC-4A6B-A132-ED6CAB30A980Q38088316-77E8CCD8-4FF0-46FB-B763-F3B3EEA92650Q38846021-DB820FA8-3CD8-4AA9-B55D-F675F282815BQ42558822-3ACA4FF0-DB1E-44E8-980E-A4E4BDA6E3B4Q48512998-4D136BD2-C6B7-4D3E-B37E-B2880FA74109
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cell and gene therapies for refractory epilepsy.
@en
Cell and gene therapies for refractory epilepsy.
@nl
type
label
Cell and gene therapies for refractory epilepsy.
@en
Cell and gene therapies for refractory epilepsy.
@nl
prefLabel
Cell and gene therapies for refractory epilepsy.
@en
Cell and gene therapies for refractory epilepsy.
@nl
P2860
P1476
Cell and gene therapies for refractory epilepsy
@en
P2093
Detlev Boison
P2860
P304
P356
10.2174/157015907780866938
P577
2007-01-01T00:00:00Z